Penn Medicine: Yeast Protein Breaks up Amyloid Fibrils and Disordered Protein Clumps In Different Ways

facebook twitter google print email
Media Contact:Karen Kreeger | Karen.kreeger@uphs.upenn.edu | 215-349-5658November 15, 2012

PHILADELPHIA ‚ÄĒ Several fatal brain disorders, including Parkinson's disease, are connected by the misfolding of specific proteins into disordered clumps and stable, insoluble fibrils called amyloid. Amyloid fibrils are hard to break up due to their stable, ordered structure. For example, a-synuclein forms amyloid fibrils that accumulate in Lewy Bodies in Parkinson's disease. By contrast, protein clumps that accumulate in response to environmental stress, such as heat shock, possess a less stable, disordered architecture.

Hsp104, an enzyme from yeast, breaks up both amyloid fibrils and disordered clumps. In the most recent issue of Cell, James Shorter, PhD, assistant professor of Biochemistry and Biophysics, and colleagues from the Perelman School of Medicine, University of Pennsylvania, show that Hsp104 switches mechanism to break up amyloid versus disordered clumps. For stable amyloid-type structures, Hsp104 needs all six of its subunits, which together make a hexamer, to pull the clumps apart. By contrast, for the more amorphous, non-amyloid clumps, Hsp104 required only one of its six subunits.

Unexpectedly, the bacterial version of the Hsp104 enzyme, called ClpB, behaves differently compared to Hsp104. Bacterial ClpB uses all six subunits to break up amorphous clumps and fails to break up amyloid fibrils. Bacteria just ignore these more stable structures, whereas yeast use Hsp104 to exploit amyloid fibrils for beneficial purposes.

‚ÄúOne surprise is that biochemists thought that Hsp104 and ClpB hexamers worked in the same way,‚ÄĚ says first author and graduate student in the Shorter lab Morgan DeSantis. ‚ÄúThis is not the case.‚ÄĚ

Hsp104 breaks up the protein clumps by ‚Äúpulling‚ÄĚ individual polypeptide chains through a channel that the hexamer forms at its center, recruiting more subunits to the job, as needed. Individual polypeptides emerge on the other side where they can be refolded into active structures. Remarkably, Hsp104 broke up various amyloid fibrils formed by proteins connected to Alzheimer‚Äôs disease (tau and Ab42), Parkinson‚Äôs disease (őĪ-synuclein), Huntington‚Äôs disease (polyglutamine), and even type II diabetes (amylin).

Click here to view the full release.

Multimedia